• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Lantheus Holdings (NQ: LNTH )

    115.74 UNCHANGED
    Streaming Delayed Price Updated: 4:00 PM EDT, Jul 18, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 22
    Open 115.74
    Bid (Size) 105.00 (1)
    Ask (Size) 121.84 (1)
    Prev. Close 115.74
    Today's Range 115.74 - 115.74
    52wk Range 50.20 - 126.89
    Shares Outstanding 67,604,097
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    Lantheus to Host Second Quarter 2024 Earnings Conference Call and Webcast on July 31, 2024, at 8:00 a.m. Eastern Time
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    Russell 2000 Marks Fifth Day Of Gains: What's Driving Surge In Small-Cap Stocks?
    Small-cap stocks, including Comfort Systems USA, Fabrinet, and Carvana, have rallied for 5 days, with iShares Russell 2000 ETF up 9% in 5 sessions. 
    Via Benzinga
    Topics ETFs

    Performance

    YTD
    +83.42%
    +83.42%
    1 Month
    +42.66%
    +42.66%
    3 Month
    +85.69%
    +85.69%
    6 Month
    +110.32%
    +110.32%
    1 Year
    +29.74%
    +29.74%

    More News

    Read More
    Massive Breakout: This ETF Signals Big Gains for Small-Cap Stocks
    Via MarketBeat
    Topics ETFs Economy
    Exposures Interest Rates
    Lantheus Acquires NAV-4694, a Next-Generation ß Amyloid PET Imaging Agent for Alzheimer’s Disease
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    Is NASDAQ:LNTH on the Verge of a Major Breakout as a Strong Growth Stock?
    Via Chartmill
    Exploring the Growth Potential of NASDAQ:LNTH as It Nears a Breakout.
    Via Chartmill
    XPeng & QuantumScape Are Among Top 11 Mid Cap Stocks That Performed Well Last Week (July 7-July 13): Details
    Via Benzinga
    Russell 2000 Index Notches Strongest Week Of Year, Hits 31-Month Highs: Outlook Is 'Clouded By Fed's Concerns Over Labor Market,' Analyst Warns
    Via Benzinga
    Topics Economy
    Exposures Interest Rates
    Stock Market Shifts Toward Small Caps After Tame CPI; JPMorgan, Taiwan Semi, Tesla In Focus: Weekly Review
    Via Investor's Business Daily
    Why ConAgra Brands Shares Are Trading Lower? Here Are Other Stocks Moving In Thursday's Mid-Day Session
    Via Benzinga
    Methode Electronics Posts Strong Sales, Joins QuantumScape, Ribbon Communications And Other Big Stocks Moving Higher On Thursday
    Via Benzinga
    Costco To Rally More Than 10%? Here Are 10 Top Analyst Forecasts For Thursday
    Via Benzinga
    New Reimbursement Rules For Diagnostic Radiopharmaceuticals Is 'Undoubtedly' Positive for Lantheus: Analyst
    Via Benzinga
    Why SeaStar Medical Holding Shares Are Trading Lower By Around 34%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Lantheus Welcomes CMS’ Proposed CY25 Rule for Improved Payment for Specialized Diagnostic Radiopharmaceuticals to Support Patient Access
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    Why Lantheus Holdings Stock Is Skyrocketing Today
    Via The Motley Fool
    SMART Global Posts Upbeat Results, Joins Aehr Test Systems, MarineMax And Other Big Stocks Moving Higher On Wednesday
    Via Benzinga
    Lantheus Stock Gets A Radioactive Surge On Medicare Proposal
    Via Investor's Business Daily
    Lantheus Appoints Jamie Spaeth as Chief People Officer
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    NASDAQ:LNTH appears to be flying under the radar despite its strong fundamentals.
    Via Chartmill
    Investors seeking growth at a reasonable cost should explore NASDAQ:LNTH.
    Via Chartmill
    Lantheus Acquires Global Rights to Life Molecular Imaging’s Novel Therapeutic and Diagnostic Pair Targeting GRPR for Prostate and Breast Cancers
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    NASDAQ:LNTH is a prime example of a stock that offers more than what meets the eye in terms of fundamentals.
    Via Chartmill
    While growth is established for NASDAQ:LNTH, the stock's valuation remains reasonable.
    Via Chartmill
    Lantheus’ AI-Enabled aPROMISE Now Available on Siemens Healthineers’ syngo.via platform
    From Lantheus Holdings, Inc.
    Via GlobeNewswire
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.